GABARONE (GABAPENTIN)
GABARONE (GABAPENTIN) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: GABARONE; Generic name: GABAPENTIN; Manufacturer: INA Pharmaceutics Inc..
| Brand name | GABARONE |
|---|---|
| Generic name | GABAPENTIN |
| Manufacturer | INA Pharmaceutics Inc. |
| Used for | 1 INDICATIONS AND USAGE GABARONE is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy GABARONE is indicated for: Postherpetic neuralgia in adults (1) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy (1) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose of 1800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures (2.2) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15mg/kg/day, given in three d |
| Active ingredient(s) | GABAPENTIN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f350a4b-f294-4b98-b69f-3cc789e930ba |